S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
S&P 500   4,967.23 (-0.88%)
DOW   37,986.40 (+0.56%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
OTCMKTS:DLHTF

Dialogue Health Technologies (DLHTF) Stock Price, News & Analysis

C$3.79
0.00 (0.00%)
(As of 10/5/2023)
Today's Range
C$3.79
C$3.79
50-Day Range
C$3.79
C$3.79
52-Week Range
C$2.43
C$3.79
Volume
N/A
Average Volume
250 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DLHTF stock logo

About Dialogue Health Technologies Stock (OTCMKTS:DLHTF)

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Its Integrated Health Platform is a healthcare hub that centralizes its programs in a single user-friendly application, which provide access to psychologists, psychotherapists, social workers, physicians, nurses, and health specialists. The company's platform also enables its members and their dependents to access employee assistance program. Dialogue Technologies Inc. was incorporated in 2016 and is headquartered in Montreal, Canada.

DLHTF Stock Price History

DLHTF Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
See More Headlines
Receive DLHTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dialogue Health Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:DLHTF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
240
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Cherif Habib (Age 41)
    Co-Founder, CEO & Director
    Comp: $437.63k
  • Mr. Alexis Smirnov (Age 52)
    Co-Founder & CTO
    Comp: $319.1k
  • Mr. Navaid Mansuri (Age 50)
    Chief Financial Officer
    Comp: $351.01k
  • Mr. Jean-Nicolas Guillemette (Age 40)
    Chief Operating Officer
    Comp: $351.01k
  • Jennifer Buckley
    Sr. Vice-Pres of Commercial
  • Mr. Jean-Marc Ayas
    Director of Investor Relations
  • Melissa Azuelos
    Gen. Counsel
  • Jean-Christophe de Le Rue
    Director of Public & Gov. Relations
  • Lilian Lau
    VP of Marketing
  • Randy Wetmore
    VP of Sales

DLHTF Stock Analysis - Frequently Asked Questions

Should I buy or sell Dialogue Health Technologies stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dialogue Health Technologies in the last twelve months. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" DLHTF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DLHTF, but not buy additional shares or sell existing shares.
View DLHTF analyst ratings
or view top-rated stocks.

How have DLHTF shares performed in 2024?

Dialogue Health Technologies' stock was trading at C$3.79 at the start of the year. Since then, DLHTF shares have increased by 0.0% and is now trading at C$3.79.
View the best growth stocks for 2024 here
.

How do I buy shares of Dialogue Health Technologies?

Shares of DLHTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DLHTF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners